Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AstraZeneca Pharma India gains CDSCO permission for Enhertu in HER2-positive solid tumours

Ruchika Sharma4 Oct 2025 11:27 AM IST

Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate...

Lupin unveils Liraglutide Injection in US for diabetes

Ruchika Sharma4 Oct 2025 10:32 AM IST

Mumbai: Global pharma major Lupin Limited has announced the launch of Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen,...

Zydus Lifesciences Dr Sharvil Patel takes over as IPA President

Ruchika Sharma3 Oct 2025 5:01 PM IST

Mumbai: The Indian Pharmaceutical Alliance (IPA) has announced a leadership transition, with Dr Sharvil Patel, Managing Director of Zydus...

Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crore

Bangalore-based Indegene acquires BioPharm from Omnicom Health Group

Ruchika Sharma3 Oct 2025 4:36 PM IST

Princeton: Indegene announced the strategic acquisition of BioPharm, a Pennsylvania-based specialized marketing services agency and part of...

Zydus-Owned Sentynl Gets USFDA Nod for First-Ever Menkes Disease Treatment ZYCUBO

Zydus's Sentynl Therapeutics pediatric Menkes disease drug flagged by USFDA

Ruchika Sharma3 Oct 2025 3:30 PM IST

Solana Beach: Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd., has...

Rajasthan Health Dept debunks cough syrup death rumours

Ruchika Sharma3 Oct 2025 2:19 PM IST

In a much-needed clarification, the Rajasthan Health Department has confirmed that the tragic deaths of two children in Bharatpur and Sikar districts...

Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma

Roche bags USFDA nod for Tecentriq plus lurbinectedin for extensive-stage small cell lung cancer

Ruchika Sharma3 Oct 2025 1:11 PM IST

Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) and Tecentriq Hybreza...

DoP invites applications for research, innovation projects under PRIP scheme

Ruchika Sharma3 Oct 2025 12:14 PM IST

New Delhi: Department of Pharmaceuticals, Government of India, has invited applications for research and innovation projects under its...

Lupin: Manufacturing Operations President Rajendra Chunodkar retires

Ruchika Sharma2 Oct 2025 2:15 PM IST

Mumbai: Lupin has announced the retirement of Rajendra Chunodkar, President - Manufacturing Operations and a member of the Senior Management of the...

Lupin signs licensing pact with Gan & Lee Pharma for GLP-1 receptor agonist Bofanglutide

Lupin unveils Rivaroxaban for Oral Suspension in US following USFDA approval

Ruchika Sharma2 Oct 2025 2:00 PM IST

Mumbai: Global pharma major Lupin Limited has announced the launch of Rivaroxaban for Oral Suspension, 1 mg/mL, in the United...

Novartis declares positive results from phase III study for new malaria treatment

Novartis Rhapsido gets USFDA nod for chronic spontaneous urticaria

Ruchika Sharma2 Oct 2025 12:30 PM IST

Basel: Novartis has announced that Rhapsido (remibrutinib) has received US Food and Drug Administration (FDA) approval as an oral treatment for...

India's pharma exports expected to cross USD 30 billion by this year end: Dr Jitendra Singh

Ruchika Sharma2 Oct 2025 11:30 AM IST

New Delhi: India's pharma exports, currently valued at nearly $27.8 billion, are expected to cross $30 billion by this year end, Union Minister of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok